General Information
Sunovion SEP361-123
An Open-Label, Fixed Sequence, Multiple Dose Study of Glucose and Insulin Associated Parameters: SEP-363856 vs Prior Antipsychotic (PA) Standard of Care in Subjects with Schizophrenia Suffering from Metabolic Dysregulation
| Protocol | SEP361-123 |
|---|---|
| Identifier | |
| UID | c48468dd-4d8a-4965-a5a9-7e502715453a |
| Status | Done - Archived |
| Phase | 1 |
| Category | Schizophrenia / Adult |
| Launch Year | 2022 |
| NCT Number | - |
| Created | 2022-08-01 14:26 |
| Last Updated | 2024-04-02 20:09 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2023-07-21 | No |
| Enrollment Open | 2022-10-05 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2022-08-12 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | No | |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | 2023-12-19 | No |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Volk, Stephen | SVolk | No |
| Recruiter | Gomez, Kathie | KGomez | No |
| Coordinator | Sandoval, Larry | LSandoval | No |
| Regulatory | Ramirez, Claudia | CRamirez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Sunovion Pharmaceuticals Inc. |
|---|---|
| Division | Sunovion Pharmaceuticals Inc. |
| Team | Sunovion Pharmaceuticals Inc. |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | IQVIA RDS Inc. |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
